CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Retained Earnings
Balance at beginning of period (in shares) at Dec. 31, 2021		110,686,000
Balance at beginning of period at Dec. 31, 2021	$ 1,381,051	$ 111	$ 1,235,903	$ (22,622)	$ 167,659
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	168,239				168,239
Other comprehensive income (loss)	(952)			(952)
Dividends declared	(48,413)				(48,413)
Net issuances of restricted stock (in shares)		598,000
Net issuances of restricted stock	0	$ 1	(1)
Stock-based compensation	15,184		15,184
Repurchases of common stock (in shares)		(537,000)
Repurchases of common stock	(62,341)	$ (1)			(62,340)
Balance at ending of period (in shares) at Mar. 31, 2022		110,747,000
Balance at end of period at Mar. 31, 2022	1,452,768	$ 111	1,251,086	(23,574)	225,145
Balance at beginning of period (in shares) at Dec. 31, 2021		110,686,000
Balance at beginning of period at Dec. 31, 2021	1,381,051	$ 111	1,235,903	(22,622)	167,659
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	344,060
Other comprehensive income (loss)	(24,985)
Balance at ending of period (in shares) at Jun. 30, 2022		109,607,000
Balance at end of period at Jun. 30, 2022	1,467,668	$ 110	1,265,495	(47,607)	249,670
Balance at beginning of period (in shares) at Mar. 31, 2022		110,747,000
Balance at beginning of period at Mar. 31, 2022	1,452,768	$ 111	1,251,086	(23,574)	225,145
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	175,821				175,821
Other comprehensive income (loss)	(24,033)			(24,033)
Dividends declared	(47,325)				(47,325)
Net issuances of restricted stock (in shares)		4,000
Stock-based compensation	14,409		14,409
Repurchases of common stock (in shares)		(1,144,000)
Repurchases of common stock	(103,972)	$ (1)			(103,971)
Balance at ending of period (in shares) at Jun. 30, 2022		109,607,000
Balance at end of period at Jun. 30, 2022	$ 1,467,668	$ 110	1,265,495	(47,607)	249,670
Balance at beginning of period (in shares) at Dec. 31, 2022	107,698,498	107,698,000
Balance at beginning of period at Dec. 31, 2022	$ 1,568,558	$ 108	1,293,565	(43,623)	318,508
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	122,005				122,005
Other comprehensive income (loss)	4,886			4,886
Dividends declared	(52,529)				(52,529)
Net issuances of restricted stock (in shares)		831,000
Net issuances of restricted stock	0	$ 1	(1)
Stock-based compensation	15,434		15,434
Repurchases of common stock (in shares)		(766,000)
Repurchases of common stock	(59,873)	$ (1)			(59,872)
Balance at ending of period (in shares) at Mar. 31, 2023		107,763,000
Balance at end of period at Mar. 31, 2023	$ 1,598,481	$ 108	1,308,998	(38,737)	328,112
Balance at beginning of period (in shares) at Dec. 31, 2022	107,698,498	107,698,000
Balance at beginning of period at Dec. 31, 2022	$ 1,568,558	$ 108	1,293,565	(43,623)	318,508
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	228,297
Other comprehensive income (loss)	$ 7,034
Balance at ending of period (in shares) at Jun. 30, 2023	107,132,280	107,132,000
Balance at end of period at Jun. 30, 2023	$ 1,625,271	$ 107	1,324,451	(36,589)	337,302
Balance at beginning of period (in shares) at Mar. 31, 2023		107,763,000
Balance at beginning of period at Mar. 31, 2023	1,598,481	$ 108	1,308,998	(38,737)	328,112
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	106,292				106,292
Other comprehensive income (loss)	2,148			2,148
Dividends declared	(51,565)				(51,565)
Net issuances of restricted stock (in shares)		23,000
Stock-based compensation	15,453		15,453
Repurchases of common stock (in shares)		(654,000)
Repurchases of common stock	$ (45,538)	$ (1)			(45,537)
Balance at ending of period (in shares) at Jun. 30, 2023	107,132,280	107,132,000
Balance at end of period at Jun. 30, 2023	$ 1,625,271	$ 107	$ 1,324,451	$ (36,589)	$ 337,302